VISHEE(SH:688580) Zheng Quan Zhi Xing·2025-06-30 16:24Core Points - The company, Nanjing Weisi Medical Technology Co., Ltd., is using its own funds to pay for investment projects and will replace these with raised funds later [1][10] - The total amount raised from the public offering was approximately RMB 1.15 billion, with a net amount of about RMB 1.06 billion after deducting issuance costs [1][10] - The company has adjusted the expected usable status dates for several projects, delaying them from September 2023 to December 2025 due to changes in internal and external environments [3][5][10] Fundraising Overview - The company issued 17,086,667 shares at a price of RMB 67.58 per share, with a face value of RMB 1.00 [1] - The total raised amount was RMB 1,154,716,955.86, with issuance costs of RMB 91,729,995.18 [1] Investment Project Status - The company has planned investments in several projects, including a research center and information technology projects, with total investment commitments adjusted to RMB 106,298.70 million [3][4] - The expected usable status for the "Research Center Construction Project" and "Information Technology Construction Project" has been extended to December 2025 [5][10] Reasons for Using Own Funds - The company needs to comply with regulations regarding salary payments, which require using basic or general deposit accounts rather than the fundraising account [7][8] - To enhance operational efficiency and reduce procurement costs, the company prefers to make bulk purchases using its own funds initially [8][9] Operational Process for Fund Replacement - The finance department will prepare detailed monthly reports on expenditures made with own funds, which will be reviewed and approved before transferring equivalent amounts from the fundraising account [9] - The company will maintain a ledger to track the replacement of funds, ensuring compliance with internal and external regulations [9][10] Impact on Daily Operations - The use of own funds for project payments and subsequent replacement with raised funds is expected to improve efficiency without affecting the normal implementation of investment projects [10] - The board and supervisory committee have approved the process, confirming that it does not harm the interests of the company or its shareholders [10][11]